Photobiomodulation Explained
What red and near infrared light therapy actually does inside your cells, what the research genuinely shows, and why wavelength choice matters more than most marketing lets on.
Introduction
Photobiomodulation, also called red light therapy or low-level laser therapy, has gone from a niche physiotherapy tool to a mainstream wellness fixture. That popularity has brought a lot of marketing language along with it, some grounded in real research, some considerably ahead of it. This article explains the actual mechanism, walks through what the evidence shows across both skin and recovery applications, and looks honestly at where the science is settled versus still developing.
What is it?
Photobiomodulation uses red and near infrared light, typically somewhere in the 600 to 1000 nanometre range, delivered by LEDs or lasers, to influence activity inside cells. Unlike more intense light or laser treatments used in aesthetic medicine, photobiomodulation works at low power, it isn't designed to heat, cut or damage tissue. Most people find sessions comfortable, though individual experiences vary. A session simply involves being exposed to the light for a set period, commonly around 20 minutes.
Why it matters
Photobiomodulation sits at an interesting intersection, the same underlying mechanism is studied across genuinely different applications, from skin rejuvenation through to muscle recovery, wound healing and even cognitive research. Understanding the mechanism helps explain why a single therapy can reasonably be offered for such a broad range of goals, without that breadth being a sign the claims are overstated, provided the specific application is backed by its own relevant evidence, not just borrowed credibility from research on a different use case.
How it works
The leading explanation for photobiomodulation's mechanism centres on an enzyme called cytochrome c oxidase, found in the mitochondrial membrane, the same energy-producing structures explored in our separate article on mitochondria and cellular energy. Cytochrome c oxidase is part of the electron transport chain, the final stage of cellular energy production, and research from Harvard Medical School's Wellman Center for Photomedicine has identified it as a primary target, or "chromophore," for red and near infrared light. When light of the right wavelength is absorbed by this enzyme, it's understood to influence the rate of electron transport, nitric oxide release, and ultimately ATP production. In damaged, fatigued or oxygen-depleted tissue specifically, where normal cellular energy production is already compromised, this effect is thought to be more pronounced than in healthy, well-oxygenated tissue functioning normally.
The dose matters, and more isn't always better
One of the more genuinely important, and less marketed, findings in this field is what researchers call a biphasic dose response. Research has consistently found that increasing the dose of light improves the response only up to a certain point, beyond that point, the benefit plateaus, then diminishes, and at very high doses, the effect can become inhibitory rather than helpful. This matters because it directly contradicts the intuitive assumption that a stronger, longer or more frequent session is automatically better. It's part of why session length and frequency are considered deliberately, not simply maximised.
Why wavelength depth matters
Different wavelengths within the red and near infrared range penetrate tissue to different depths, and this is genuinely mechanistically relevant, not just a specification detail. Shorter red wavelengths, broadly in the 590 to 630 nanometre range, are absorbed more superficially, closer to the skin's surface, which is why they're commonly associated with skin-focused outcomes like tone and texture. Longer red and near infrared wavelengths, extending toward 850 nanometres, penetrate further, reaching muscle and joint tissue, which is why they're more relevant to recovery-focused applications. A device using only one or two wavelengths is genuinely limited in which depths of tissue it can meaningfully influence, this is a real, mechanism-based reason multi-wavelength devices can offer broader coverage, not simply a bigger specification number for its own sake.
LED versus laser delivery
Photobiomodulation can be delivered through either LEDs or lasers, and the distinction is worth understanding, since it's sometimes glossed over in wellness marketing. Lasers deliver coherent, single-wavelength light in a tightly focused beam, historically the format used in much of the earliest clinical research. LED-based systems, increasingly common in wellness settings, deliver a wider treatment area at once, and modern LED arrays can combine multiple wavelengths within a single panel. Research broadly suggests both delivery methods can produce genuine photobiomodulation effects, provided the wavelength, dose and treatment area are appropriate, coherence itself doesn't appear to be a strict requirement for the underlying cellular mechanism, though this remains an area some researchers continue to investigate rather than a fully settled question.
What actually happens in the hours and days after a session
Photobiomodulation isn't generally described as producing an immediate, dramatic change during the session itself, most of the proposed biological activity, increased ATP production, altered gene expression, changes in inflammatory signalling, unfolds over the hours and days following exposure, not during the light exposure itself. This is part of why the research consistently points toward a course of regular sessions rather than a single visit, the cellular effects are understood to be cumulative, building through repeated, appropriately spaced exposure rather than accumulating from one long session.
Current evidence
It's worth being specific here about what type of evidence exists, since not all research carries equal weight.
Clinical evidence: A randomised, double-blinded, placebo-controlled crossover trial examined whether photobiomodulation affects maximal muscle strength and recovery after resistance exercise. Separately, a randomised controlled trial testing red and amber LED protocols around the eye area, at matched light doses, found a 30% reduction in wrinkle volume measured using 3D imaging against a control group. Both are genuine controlled trials, with randomisation and comparison groups, the stronger tier of clinical evidence.
Emerging evidence: A 2023 systematic review examined the oncologic safety of low-level light therapy used for aesthetic skin rejuvenation. It included seven clinical PBM trials; mild transient erythema was reported in four patients, with no other adverse events reported in those trials. The review focused on oncologic safety in this specific application and does not establish the safety of every PBM device, wavelength, dose or protocol. Further research and standardised protocols are needed.
Theoretical mechanism: The cytochrome c oxidase pathway, and its downstream effects on nitric oxide release and mitochondrial function, represents an active area of mechanistic research. It offers a genuinely plausible explanation for why photobiomodulation might work, but mechanism research and clinical outcome research are different questions, one explains a "why," the other measures a "what happens."
Clinical considerations
Photobiomodulation is generally considered low-risk, but it isn't automatically appropriate for everyone. People taking photosensitising medication, those with a history of skin cancer, and pregnant women are commonly advised to discuss suitability with a practitioner before beginning. As with any therapy discussed in this Knowledge Hub, general wellness use is a different context to treating a diagnosed medical condition, and shouldn't be treated as equivalent.
Who may benefit
Based on current research, photobiomodulation is commonly considered by people managing persistent muscle or joint discomfort, athletes seeking recovery support around training, and people interested in skin tone, texture and general tissue health. As with every therapy discussed here, individual responses vary, and it isn't positioned as a guaranteed outcome for any specific condition.
A note on how this connects across our services
You'll notice photobiomodulation referenced across several of our other service pages, not just its own. That's intentional, not repetition for its own sake. The same underlying mitochondrial mechanism genuinely connects HBOT, red light therapy and general cellular health conversation, and we think it's more honest to show that connection clearly than to present each therapy as an entirely separate, unrelated offering when the biology says otherwise.
Common questions
No. Research describes a biphasic dose response, benefit increases up to a point, then plateaus and can even reverse at very high doses. This is exactly why session length and frequency are chosen deliberately, not maximised.
Different wavelengths penetrate tissue to different depths. Shorter wavelengths work closer to the skin's surface, longer near infrared wavelengths reach muscle and joint tissue. This is a genuine mechanistic difference, not just a marketing specification.
They share the same underlying mechanism, but the specific clinical evidence differs by application. We've referenced separate studies for skin and for muscle recovery in this article for exactly that reason.
HBOT increases how much oxygen your blood delivers to tissue. Photobiomodulation is understood to support how efficiently mitochondria use that oxygen to produce energy. The two are mechanistically complementary, which is why many clients pair them.
Related My BioHealth services
for wavelength details, session information and booking. See also our article on for the underlying biology, and , commonly paired with red light for complementary mechanisms.
References
- Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. View study →
- Does Photobiomodulation Therapy Enhance Maximal Muscle Strength and Muscle Recovery? PubMed. View study →
- Photobiomodulation Reduces Periocular Wrinkle Volume: A Randomized Controlled Trial. Photobiomodulation, Photomedicine, and Laser Surgery. View study →
- Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation. Aesthetic Surgery Journal, Oxford Academic. View study →